Cristiane ‘Cyborg’ Justino has been alerted that she potentially violated the UFC’s agreement with USADA when she failed an out-of-competition drug test that was taken on Dec 5.
Cyborg made headlines recently as it appeared she was slighted by UFC executives after Holly Holm and Germaine de Randamie were given the inaugural UFC women’s Featherweight Championship bout at UFC 208 on February 11.
Cyborg actually turned the title fight down, citing the difficult weight cut ahead of her UFC Fight Night 95 bout with Lina Länsberg — where Cyborg cut 24 pounds to make a 140lb catchweight limit.
Cyborg was previously suspended in 2012 for one-year after the female fighter tested positive for stanozolol, when fought for Strikeforce.
Update: Marc Raimondi of MMAFighting.com has reported that Cyborg failed her test on December 5 for a diuretic and will face a one-year suspension from USADA.
OFFICIAL UFC STATEMENT ON CYBORG:
The UFC organization was formally notified today that the U.S. Anti-Doping Agency (USADA) has informed Cristiane “Cyborg” Justino of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collection on December 5, 2016.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed.
Consistent with all previous potential anti-doping violations, additional information or UFC statements will be provided at the appropriate time as the process moves forward.
